Transcatheter Mitral Annuloplasty for Functional Mitral Regurgitation

October 23, 2017 | Technology Forecasts


Note: The following ratings and comments reflect the opinions and consensus of an expert panel convened by ECRI Institute to review information on this topic.

Anticipated Utilization: 2(Expected to be used by 20% to 40% of eligible patients)

About 220,000 of the estimated 4.2 million cases of functional mitral regurgitation are severe and symptomatic, and this population has an unmet need for effective treatments. Catheter-based annuloplasty devices would likely be indicated for certain subsets of these patients, such as those deemed unsuitable for open heart surgery. The catheter approach for each device would also likely affect which subset of patients is eligible for a particular device. Physicians will require positive outcomes data from large randomized trials to fully accept this technology.

Estimated Adoption Status: 1 (Early...

Access Full Content

Contact us today at 610.825.6000.